Phillips O P, Seely L, Wan J Y, Wachtel S S, Shulman L P
Department of Obstetrics and Gynecology, University of Tennessee, Memphis, Tenn. 39103, USA.
Fetal Diagn Ther. 1998 Nov-Dec;13(6):357-60. doi: 10.1159/000020869.
We asked two groups of women their opinion on prenatal diagnosis and maternal serum screening (MSS): group 1 comprised women who had undergone a prenatal diagnostic procedure (amniocentesis or chorionic villus sampling) for advanced maternal age (>/=35 years) and group 2 women who had undergone MSS and were 30-34 years old. Women in group 1 were found significantly less likely to choose MSS over prenatal diagnosis than were women in group 2. The sensitivity of MSS and the age-related risk of chromosome abnormalities influenced opinions on whether to choose MSS or prenatal diagnosis. In both groups, the majority stated that they would accept MSS over prenatal diagnosis, if their obstetrician recommended it.
我们询问了两组女性对产前诊断和母血清筛查(MSS)的看法:第一组包括因母亲年龄较大(≥35岁)而接受过产前诊断程序(羊膜穿刺术或绒毛取样)的女性,第二组是接受过MSS且年龄在30 - 34岁的女性。结果发现,与第二组女性相比,第一组女性选择MSS而非产前诊断的可能性显著更低。MSS的敏感性以及与年龄相关的染色体异常风险影响了关于选择MSS还是产前诊断的看法。在两组中,大多数人表示,如果产科医生推荐,她们会接受MSS而非产前诊断。